"Excellent finish to the year with strong growth and high profitability" Fourth quarter and full year summary October - December Total revenues grew 48% (44% at CER1) to SEK 553 (375) million Sales ...

Novo Nordisk shares dropped due to CagriSema trial results but have long-term upside. Learn why NVO stock is a Strong Buy ...

On December 27, 2024, the US Food and Drug Administration (FDA) published its final rule to update the definition for “healthy” claims on food ...

OKYO Pharma Limited (NASDAQ: OKYO), a clinical-stage biopharmaceutical company developing innovative therapies for the treatment of neuropathic corneal ...

Compounded weight-loss medications, such as those promoted in the Hims & Hers commercial, aren’t approved by the Food and Drug Administration.

The FDA has upgraded a broccoli recall to Class I due to potential Listeria contamination in Walmart-sold products.

A recovering ketamine addict from Portsmouth warns of the drug's dangers as use soars among young people. The number treated across the region was an increase on the previous year. The early ...

The Food and Drug Administration has reclassified ... In the Jan. 29 weekly enforcement report, the FDA classified the recall of eight Cal Yee Farm products as a "Class I" designation.

Patients seeking an opioid-free way to handle pain experienced in the short-term will soon have a new option.

The drug, shown to be almost as effective as opioids for short-term pain, is the first fundamentally new kind of painkiller ...

Vertex Pharmaceuticals (VRTX) stock rose on Friday after the Food and Drug Administration (FDA) approved its new ... opioid painkiller and the first new class of pain medicine approved in more ...